Provided by Tiger Trade Technology Pte. Ltd.

Eli Lilly

1,255.40
+11.000.88%
Post-market: 1,254.06-1.3400-0.11%19:59 EDT
Volume:2.50M
Turnover:3.14B
Market Cap:1.19T
PE:42.14
High:1,271.22
Open:1,232.00
Low:1,230.00
Close:1,244.40
52wk High:1,292.65
52wk Low:694.23
Shares:945.38M
Float Shares:939.00M
Volume Ratio:0.91
T/O Rate:0.27%
Dividend:6.46
Dividend Rate:0.51%
EPS(TTM):29.79
EPS(LYR):22.95
ROE:102.29%
ROA:20.36%
PB:35.03
PE(LYR):54.70

Loading ...

Movement Alert|Eli Lilly Intraday Rise 5.71%, Q2 Earnings Significantly Beat Expectations with Revenue Guidance Raised

Market Focus
·
Aug 05

Eli Lilly and Company Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Sector Update: Healthcare

MT Newswires Live
·
Aug 05

Eli Lilly Posts Q2 Revenue Growth Driven by Soaring GLP-1 Drug Demand

Deep News
·
Aug 05

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth

Bloomberg
·
Aug 05

U.S. Stocks on the MOVE-Arista Networks, CVS, Eli Lilly, Phillips 66

Reuters
·
Aug 05

US Stocks-S&P 500, Dow Futures Inch up as Mideast Hopes Offset SpaceX, AMD Drag

Reuters
·
Aug 05

Eli Lilly's second-quarter revenue hits $22.97 billion, surpassing expectations of $20.59 billion

Deep News
·
Aug 05

Eli Lilly's stock surges 6% in pre-market trading after strong Q2 earnings beat

Deep News
·
Aug 05

Weight Loss Drug Demand Surges, Eli Lilly's Q2 Revenue Soars 48% Year-Over-Year, Full-Year Guidance Raised to $85-87 Billion | Earnings Report

Deep News
·
Aug 05

Lilly's Revenue Soars 48%, Driven by Demand of Its GLP-1s

Dow Jones
·
Aug 05

Lilly Q2 Adjusted EPS USD 8.38 Vs. IBES Estimate USD 6.01

Reuters
·
Aug 05

Lilly Q2 2026 Earnings: Mounjaro and Zepbound Drive 48% Revenue Growth

TradingKey
·
Aug 05

Lilly Beats Estimates on Resilient Demand for Injectable GLP-1 Drugs, Widens Gap with Novo

Reuters
·
Aug 05

Lilly Climbs on Annual Revenue Forecast Raise

Reuters
·
Aug 05

GUIDANCE: (LLY) Eli Lilly Expects 2026 Revenue Range $85B to $87B, vs. FactSet Est of $85.28B

MT Newswires Live
·
Aug 05

Eli Lilly Shares up 4.3% Premarket After Q2 Results Beat Estimates

THOMSON REUTERS
·
Aug 05

Eli Lilly Q2 FY26 EPS Rises 26% to $7.94; Revenue Increases 48% to $23 Billion

Reuters
·
Aug 05

Stock Track | Eli Lilly Soars 5.11% in Pre-market on CVS GLP-1 Partnership and Novo Nordisk Pipeline Setbacks

Stock Track
·
Aug 05

Eli Lilly Q2 Adj. EPS $8.38 Beats $6.01 Estimate, Sales $22.974B Beat $20.725B Estimate

Benzinga Earnings
·
Aug 05